Creative Medical Technology enters warrant exercise deals for USD 4.5 million proceeds

Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc.

CELZ

0.00
  • Creative Medical Technology Holdings reached agreements for immediate cash exercise of October 2025 warrants for 2,790,340 shares at USD 1.6.
  • Gross proceeds expected at about USD 4.5 million; closing set for June 30, 2026.
  • Issuing new unregistered warrants for up to 5,580,680 shares at USD 1.6, exercisable upon shareholder approval for five years.
  • New warrants offered in a private placement; company plans to file an SEC resale registration statement for shares issuable on exercise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Creative Medical Technology Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606301407PRIMZONEFULLFEED9755003) on June 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.